Genetic variations of CYP3A4 on the metabolism of itraconazole in vitro.


Journal

Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association
ISSN: 1873-6351
Titre abrégé: Food Chem Toxicol
Pays: England
ID NLM: 8207483

Informations de publication

Date de publication:
Nov 2023
Historique:
received: 12 08 2023
revised: 11 10 2023
accepted: 12 10 2023
medline: 6 11 2023
pubmed: 21 10 2023
entrez: 20 10 2023
Statut: ppublish

Résumé

Itraconazole is a triazole anti-infective drug that has been proven to prevent and treat a variety of fungal and viral infections and has been considered to be a potential therapeutic remedy for COVID-19 treatment. In this study, we aimed to completely evaluate the impacts of Cytochrome P450 3A4 (CYP3A4) variant proteins and drug interactions on the metabolism of itraconazole in recombinant insect microsomes, and to characterize the potential mechanism of substrate selectivity. Incubations with itraconazole (0.2-15 μM) in the presence/absence of lopinavir or darunavir were assessed by CYP3A4 variants, and the metabolite hydroxyitraconazole concentrations were measured by UPLC-MS/MS. Our data showed that when compared with CYP3A4.1, 4 variants (CYP3A4.9, .10, .28 and .34) displayed no significant differences, and 3 variants (CYP3A4.14, .15 and .19) exhibited increased intrinsic clearance (CL

Identifiants

pubmed: 37863381
pii: S0278-6915(23)00503-3
doi: 10.1016/j.fct.2023.114101
pii:
doi:

Substances chimiques

Itraconazole 304NUG5GF4
Cytochrome P-450 CYP3A EC 1.14.14.1
Lopinavir 2494G1JF75
Darunavir YO603Y8113
CYP3A4 protein, human EC 1.14.14.55

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

114101

Informations de copyright

Copyright © 2023 Elsevier Ltd. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Auteurs

Sai-Li Xie (SL)

The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, China.

Xiayan Zhu (X)

The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, China.

Nanyong Gao (N)

School of Pharmaceutical Sciences, Wenzhou Medical University, Wenzhou, Zhejiang, China.

Qianmeng Lin (Q)

School of Pharmaceutical Sciences, Wenzhou Medical University, Wenzhou, Zhejiang, China.

Chaojie Chen (C)

The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, China.

Yun-Jun Yang (YJ)

The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, China. Electronic address: yyjunjim@163.com.

Jian-Ping Cai (JP)

The Key Laboratory of Geriatrics, Beijing Institute of Geriatrics, Institute of Geriatric Medicine, Chinese Academy of Medical Sciences, Beijing Hospital/National Center of Gerontology of National Health Commission, Beijing, China. Electronic address: caijp61@vip.sina.com.

Guo-Xin Hu (GX)

School of Pharmaceutical Sciences, Wenzhou Medical University, Wenzhou, Zhejiang, China. Electronic address: hgx@wmu.edu.cn.

Ren-Ai Xu (RA)

The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, China. Electronic address: xra@wmu.edu.cn.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH